77 results
POS AM
SPRC
SciSparc Ltd
2 May 24
Prospectus update (post-effective amendment)
5:17pm
strategy;
litigation; and
those factors discussed in the section “Risk Factors” beginning on page 4 of this prospectus.
These statements are only … and investments in other companies that may not necessarily be aligned with our current business strategy. We cannot provide any assurance that we
20-F/A
2023 FY
SPRC
SciSparc Ltd
2 May 24
Annual report (foreign) (amended)
9:18am
a different business strategy and began focusing on developing a portfolio of approved drugs based on cannabinoid molecules. With this focus, the Company
425
SPRC
SciSparc Ltd
12 Apr 24
Business combination disclosure
9:23am
commercialization, marketing and manufacturing capabilities and strategy; risks related to the combined company’s ability to protect its intellectual … capabilities and strategy; risks related to the combined company’s ability to protect its intellectual property position; and the requirement for additional
6-K
EX-99.3
SPRC
SciSparc Ltd
11 Apr 24
Agreement and Plan of Merger
4:05pm
and strategy; risks related to the combined company’s ability to protect its intellectual property position; and the requirement for additional capital
6-K
SPRC
SciSparc Ltd
11 Apr 24
Agreement and Plan of Merger
4:05pm
to the combined company’s commercialization, marketing and manufacturing capabilities and strategy; risks related to the combined company’s ability to protect
F-1
xhzs4ik279l7 x23t
27 Feb 24
Registration statement (foreign)
4:15pm
F-3/A
6fj04d3x qlishp
20 Nov 23
Shelf registration (foreign) (amended)
4:22pm
F-3
d40tnnzp1arz5
3 Nov 23
Shelf registration (foreign)
4:06pm
6-K
EX-99.2
7oq4m4wz99cw
16 Oct 23
Interim Consolidated Financial Statements
5:00pm
6-K
EX-99.1
vxn0fw chlofci
16 Oct 23
Interim Consolidated Financial Statements
5:00pm
6-K
EX-99.1
p092653co q3og
19 Sep 23
SciSparc Engages Investment Bank to Identify Potential Strategic Transaction Opportunities
6:16pm
6-K
gxpnex
14 Aug 23
SciSparc Ltd. Announces Pricing of $1.3 Million Underwritten Public Offering
4:31pm
424B5
5hjrn1xgmnky9p4ut
14 Aug 23
Prospectus supplement for primary offering
9:14am
424B3
l8obu
10 Aug 23
Prospectus supplement
6:32am
6-K
gq0mg 2vqhgiwwz
30 May 23
SciSparc Makes Another Step Towards Unlocking Potential Value Appoints New Strategy and Business Development VP
4:01pm
6-K
EX-99.1
pdlms1r
30 May 23
SciSparc Makes Another Step Towards Unlocking Potential Value Appoints New Strategy and Business Development VP
4:01pm
424B5
3lfqmc29d 6ztut
16 May 23
Prospectus supplement for primary offering
5:30pm
6-K
EX-99.1
v2sc5wg r9j345
29 Dec 22
Interim Consolidated Financial Statements
4:03pm